134 related articles for article (PubMed ID: 37937300)
1. The intensity of free radical processes and chaperone activity in the saliva of patients with type 2 diabetes.
Cheprasova AA; Popov SS; Pashkov AN; Verevkin AN; Mittova VO; Shulgin KK
Biomedicine (Taipei); 2023; 13(2):56-61. PubMed ID: 37937300
[TBL] [Abstract][Full Text] [Related]
2. Parameters of Oxidative Stress and Activity of Antioxidant Enzymes in the Saliva of Patients with Type 1 Diabetes Mellitus.
Cheprasova AA; Popov SS; Pashkov AN; Verevkin AN; Shul'gin KK
Bull Exp Biol Med; 2022 Mar; 172(5):552-557. PubMed ID: 35348957
[TBL] [Abstract][Full Text] [Related]
3. Elevated urinary levels of 8-oxo-2'-deoxyguanosine, (5'R)- and (5'S)-8,5'-cyclo-2'-deoxyadenosines, and 8-iso-prostaglandin F
Kant M; Akış M; Çalan M; Arkan T; Bayraktar F; Dizdaroglu M; İşlekel H
DNA Repair (Amst); 2016 Dec; 48():1-7. PubMed ID: 27769710
[TBL] [Abstract][Full Text] [Related]
4. Salivary inflammatory biomarkers and glycated haemoglobin among patients with type 2 diabetic mellitus.
Agho ET; Owotade FJ; Kolawole BA; Oyetola EO; Adedeji TA
BMC Oral Health; 2021 Mar; 21(1):101. PubMed ID: 33676486
[TBL] [Abstract][Full Text] [Related]
5. Free radicals related effects and antioxidants in saliva and serum of adolescents with Type 1 diabetes mellitus.
Reznick AZ; Shehadeh N; Shafir Y; Nagler RM
Arch Oral Biol; 2006 Aug; 51(8):640-8. PubMed ID: 16620776
[TBL] [Abstract][Full Text] [Related]
6. Use of Saliva to Assess the Adherence to Treatment with Oral Hypoglycemic Agents in Patients with Type 2 Diabetes.
de Faria Baltazar H; Fonseca FLA; Castelo PM; da Costa Aguiar Alves B; Gascón T; da Veiga GL; Pereira EC
Endocr Metab Immune Disord Drug Targets; 2023; 23(8):1068-1076. PubMed ID: 36627777
[TBL] [Abstract][Full Text] [Related]
7. Salivary and serum oxidative stress biomarkers and advanced glycation end products in periodontitis patients with or without diabetes: A cross-sectional study.
Altıngöz SM; Kurgan Ş; Önder C; Serdar MA; Ünlütürk U; Uyanık M; Başkal N; Tatakis DN; Günhan M
J Periodontol; 2021 Sep; 92(9):1274-1285. PubMed ID: 33277933
[TBL] [Abstract][Full Text] [Related]
8. Altered redox homeostasis in human diabetes saliva.
Su H; Velly AM; Salah MH; Benarroch M; Trifiro M; Schipper HM; Gornitsky M
J Oral Pathol Med; 2012 Mar; 41(3):235-41. PubMed ID: 22077396
[TBL] [Abstract][Full Text] [Related]
9. Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin.
Gozel N; Kilinc F
Endokrynol Pol; 2021; 72(1):37-43. PubMed ID: 32944923
[TBL] [Abstract][Full Text] [Related]
10. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
[TBL] [Abstract][Full Text] [Related]
11. High-Intensity Interval Training Improves Glycemic Control, Cellular Apoptosis, and Oxidative Stress of Type 2 Diabetic Patients.
Al-Rawaf HA; Gabr SA; Iqbal A; Alghadir AH
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512131
[No Abstract] [Full Text] [Related]
12. Correlation of Toll-like receptor 4, interleukin-18, transaminases, and uric acid in patients with chronic periodontitis and healthy adults.
Banu S; Jabir NR; Mohan R; Manjunath NC; Kamal MA; Kumar KR; Zaidi SK; Khan MS; Tabrez S
J Periodontol; 2015 Mar; 86(3):431-9. PubMed ID: 25345339
[TBL] [Abstract][Full Text] [Related]
13. Serum and salivary ferritin and Hepcidin levels in patients with chronic periodontitis and type 2 diabetes mellitus.
Guo LN; Yang YZ; Feng YZ
BMC Oral Health; 2018 Apr; 18(1):63. PubMed ID: 29636044
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Salivary Antioxidants and Oxidative Stress Markers in Type 2 Diabetes Mellitus: A Retrospective Cohort Study.
Fathi S; Borzouei S; Goodarzi MT; Poorolajal J; Ahmadi-Motamayel F
Endocr Metab Immune Disord Drug Targets; 2020; 20(4):584-590. PubMed ID: 31622212
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of salivary α2 macroglobulin in patients with type 2 diabetes mellitus.
Feng JK; Lu YF; Li J; Qi YH; Yi ML; Ma DY
Genet Mol Res; 2015 Mar; 14(1):2268-74. PubMed ID: 25867373
[TBL] [Abstract][Full Text] [Related]
16. Literature-based discovery of salivary biomarkers for type 2 diabetes mellitus.
Srinivasan M; Blackburn C; Mohamed M; Sivagami AV; Blum J
Biomark Insights; 2015; 10():39-45. PubMed ID: 26005324
[TBL] [Abstract][Full Text] [Related]
17. Estimation of Salivary and Serum Biomarkers in Diabetic and Non Diabetic Patients - A Comparative Study.
Ladgotra A; Verma P; Raj SS
J Clin Diagn Res; 2016 Jun; 10(6):ZC56-61. PubMed ID: 27504412
[TBL] [Abstract][Full Text] [Related]
18. 8-hydroxy-deoxyguanosine levels in gingival crevicular fluid and saliva in patients with chronic periodontitis after initial periodontal treatment.
Dede FÖ; Ozden FO; Avcı B
J Periodontol; 2013 Jun; 84(6):821-8. PubMed ID: 22897655
[TBL] [Abstract][Full Text] [Related]
19. Salivary human beta-defensins and cathelicidin levels in relation to periodontitis and type 2 diabetes mellitus.
Yilmaz D; Topcu AO; Akcay EU; Altındis M; Gursoy UK
Acta Odontol Scand; 2020 Jul; 78(5):327-331. PubMed ID: 31980002
[No Abstract] [Full Text] [Related]
20. Common Salivary Protein 1 in Saliva of Diabetes Patients (II).
Zhang L; Wang H; Jin HY; Kim JC; Oh SW
Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
